COVID-19 vaccine-taking hesitancy among Bangladeshi people: knowledge, perceptions and attitude perspective.

Bangladesh COVID-19 vaccine attitude hesitancy knowledge perception sustainable health

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
02 Nov 2021
Historique:
pubmed: 24 9 2021
medline: 15 1 2022
entrez: 23 9 2021
Statut: ppublish

Résumé

Several novel efforts have been put forth to make a readily available vaccine against the global pandemic of COVID-19. However, there seems to appear vaccine-taking hesitancy among the general people. Against this backdrop, this current study sets to assess the vaccine-taking intention, ways to overcome the vaccine-taking reluctance among Bangladeshi people and explore their knowledge, perceptions, and attitude toward the COVID-19 vaccine. To this end, this study leveraged on a cross-sectional survey, which was consisted of 1377 respondents covering the eight divisions of Bangladesh. The descriptive statistical method and ordinal logistics regression were employed to explore and rationalize our study outlined objectives. Empirical findings revealed that approximately 71% of the respondents had adequate knowledge about the COVID-19 vaccine, whereas 46% of the respondents were willing to be vaccinated against COVID-19 while the rest of the respondents were hesitant to take the vaccine. However, concern about the potential side effects was one of the core reasons for vaccine-taking hesitancy. Assuring the common people about vaccine safety and efficacy, along with easing the registration procedure, can ameliorate people's confidence to get vaccinated. Meanwhile, about 60% of the respondents believed that a vaccine could help Bangladesh win the battle against COVID-19 and will allow back to normal life. Although the government has taken some pragmatic action steps to promote the vaccination rate, it is recommended that the mass vaccination program should be extended to the grassroots level with proper extension community support and easing the registration process.

Identifiants

pubmed: 34554050
doi: 10.1080/21645515.2021.1968215
pmc: PMC8828157
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4028-4037

Références

Environ Sci Pollut Res Int. 2020 Dec;27(36):45949-45956
pubmed: 33064278
Hum Vaccin Immunother. 2021 Jul 3;17(7):2279-2288
pubmed: 33522405
Lancet. 2020 Sep 19;396(10254):810-811
pubmed: 32950081
Health Policy. 2020 May;124(5):511-518
pubmed: 32276852
Nature. 2020 Mar;579(7799):321
pubmed: 32179860
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Br J Health Psychol. 2021 May;26(2):553-569
pubmed: 33099800
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
J Am Geriatr Soc. 2020 May;68(5):926-929
pubmed: 32255507
J Med Virol. 2020 Jul;92(7):786-790
pubmed: 32320066
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
PLoS One. 2020 Sep 2;15(9):e0238492
pubmed: 32877449
Vaccine. 2020 Dec 3;38(51):8090-8098
pubmed: 33187765
Int J Public Health. 2020 Jul;65(6):711-712
pubmed: 32529534
Hum Vaccin Immunother. 2021 Oct 3;17(10):3365-3370
pubmed: 34236952
Science. 2020 Oct 16;370(6514):286-288
pubmed: 32958582
Heliyon. 2020 May;6(5):e04063
pubmed: 32462098
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS One. 2016 Mar 16;11(3):e0151258
pubmed: 26982071
J Soc Econ Dev. 2021 Jan 6;:1-11
pubmed: 34720480
J Antimicrob Chemother. 2020 Dec 1;75(12):3413-3416
pubmed: 32830266
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Z Gesundh Wiss. 2021 Jan 16;:1-11
pubmed: 33489718
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Environ Dev Sustain. 2020 Oct 8;:1-12
pubmed: 33052193
Vaccines (Basel). 2020 Dec 18;8(4):
pubmed: 33352835
Eur J Epidemiol. 2020 Aug;35(8):781-783
pubmed: 32761440
Nat Rev Immunol. 2020 Oct;20(10):583-584
pubmed: 32908300
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Int J Biol Sci. 2020 Mar 15;16(10):1678-1685
pubmed: 32226285
Vaccine. 2012 May 28;30(25):3778-89
pubmed: 22172504
Int J Infect Dis. 2020 Sep;98:14-15
pubmed: 32585285
Asia Pac J Public Health. 2021 Jan;33(1):100-108
pubmed: 33289393
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
BMC Public Health. 2021 Oct 13;21(1):1851
pubmed: 34645399
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
Lancet Rheumatol. 2020 Sep;2(9):e514-e516
pubmed: 32838308

Auteurs

Emran Hossain (E)

Department of Agricultural Finance and Banking, Bangladesh Agricultural University, Mymensingh, Bangladesh.

Jaber Rana (J)

Department of Agricultural Economics, Khulna Agricultural University, Khulna, Bangladesh.

Sayemul Islam (S)

Faculty of Agricultural Economics & Rural Sociology, Bangladesh Agricultural University, Mymensingh, Bangladesh.

Akhtaruzzaman Khan (A)

Department of Agricultural Finance and Banking, Bangladesh Agricultural University, Mymensingh, Bangladesh.

Sudipto Chakrobortty (S)

Faculty of Agricultural Economics & Rural Sociology, Bangladesh Agricultural University, Mymensingh, Bangladesh.

Nishat Sultana Ema (NS)

Faculty of Agricultural Economics & Rural Sociology, Bangladesh Agricultural University, Mymensingh, Bangladesh.

Festus Victor Bekun (FV)

Faculty of Economics Administrative and Social Sciences, Istanbul Gelisim University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH